Hypophosphatemia, a poorly known adverse reaction of intravenous use of iron;Hipofosfatemia, una reacción adversa poco conocida del hierro intravenoso

Medicina Clinica

Volumn 143, Issue 6, 2014, Pages 283-284

  Barea Mendoza, Jesús Abelardo ^a   Gredilla Zubiría, Íñigo ^a   González Olmedo, Jesús ^a   Mateo Alvarez, Salvador ^a  

^a HOSPITAL UNIVERSITARIO 12 DE OCTUBRE   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

IRON; FERRIC CARBOXYMALTOSE; FERRIC ION; FIBROBLAST GROWTH FACTOR; FIBROBLAST GROWTH FACTOR 23; MALTOSE;

ADVERSE DRUG REACTION; HUMAN; HYPOPHOSPHATEMIA; LETTER; AGED; ANALOGS AND DERIVATIVES; ANEMIA, IRON-DEFICIENCY; BLOOD; CASE REPORT; CHEMICALLY INDUCED; CHRONIC HEPATITIS C; COMPLICATION; EPIDEMIOLOGY; HYPOCALCEMIA; INTRAVENOUS DRUG ADMINISTRATION; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; PHYSIOLOGY;

AGED; ANEMIA, IRON-DEFICIENCY; CAUSALITY; DIABETES MELLITUS, TYPE 2; FERRIC COMPOUNDS; FIBROBLAST GROWTH FACTORS; HEPATITIS C, CHRONIC; HUMANS; HYPOCALCEMIA; HYPOPHOSPHATEMIA; INFUSIONS, INTRAVENOUS; MALE; MALTOSE;

EID: 84929940148     PISSN: 00257753     EISSN: 15788989     Source Type: Journal    
DOI: 10.1016/j.medcli.2013.11.030     Document Type: Letter

References (8)

1. ®. Agencia Española del Medicamento [publicación electrónica]. 2008 [consultado Ago 2012]. Disponible en: http://www.aemps.gob.es/cima/pdfs/es/p/69771/P-69771.pdf
2. Holloway K, Green T. Comités de farmacoterapia - Guía práctica [publicación electrónica]. Ginebra, Suiza: Organización Mundial de la Salud; 2003. p. 64-77 [consultado Ago 2012]. Disponible en: http://apps.who.int/medicinedocs/es/d/Js8121s
3. C.F. Barish, T. Koch, A. Butcher, D. Morris, and D.B. Bregman Safety and efficacy of intravenous ferric carboxymaltose (750 mg) in the treatment of iron deficiency anemia: Two randomized, controlled trials Anemia 2012 2012 172104
4. R.A. Moore, H. Gaskell, P. Rose, and J. Allan Meta-analysis of efficacy and safety of intravenous ferric carboxymaltose (Ferinject) from clinical trial reports and published trial data BMC Blood Disord 11 2011 4
5. L.Y. Mani, G. Nseir, J.P. Venetz, and M.H. Pascual Severe hypophosphatemia after intravenous administration of iron carboxymaltose in a stable renal transplant recipient Transplantation 90 2010 804 805
6. Y. Shimizu, Y. Tada, M. Yamauchi, T. Okamoto, H. Suzuki, and N. Ito et al. Hypophosphatemia induced by intravenous administration of saccharated ferric oxide: Another form of FGF23-related hypophosphatemia Bone 45 2009 814 816
7. B.J. Schouten, P.J. Hunt, J.H. Livesey, C.M. Frampton, and S.G. Soule FGF23 elevation and hypophosphatemia after intravenous iron polymaltose: A prospective study J Clin Endocrinol Metab 94 2009 2332 2337
8. N. Blanco Rubio, M. Llorens Eizaguerri, B. Seral García, P. Burillo Fuertes, M. Ranera García, and J. Albareda Albareda Hierro intravenoso preoperatorio como estrategia de ahorro de sangre en cirugIa de fractura de cadera Med Clin (Barc) 141 2013 371 375